IGM Biosciences Stock Quote IGMS - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

17.68

Bid

17.32

Ask

19.00

Volume

0.00 Day's Range 0.00

3.81 52 Week Range 22.50

Market Cap

1.049B

Previous Close

17.68

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

308,959

Shares Outstanding

59,318,669

Dividend Yield

PE Ratio

-4.26

Earnings Per Share (EPS)

-4.15

Revenue

2.13M

Net Profit

-246.42M

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking ago... IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, IGM-2323, is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 protein, IGM-8444, a combination with a chemotherapeutic agent such as irinotecan, gemcitabine, or venetoclax, and IGM-7354, a bispecific IgM antibody delivering interleukin-15 (IL-15) cytokines to PD-L1 expressing cells for the treatment of patients with solid and hematologic malignancies. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.igmbio.com

Headquarters

Dover, Delaware, USA

Founded

IGM Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker IGMS. The last closing price for IGM Biosciences was $17.68. Over the last year, IGM Biosciences shares have traded in a share price range of $ 3.81 to $ 22.50.

IGM Biosciences currently has 59,318,669 shares outstanding. The market capitalization of IGM Biosciences is $1.05 billion. IGM Biosciences has a price to earnings ratio (PE ratio) of -4.26.

Form 4 - Statement of changes in beneficial ownership of securities

FeaturedMawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt

IGM Biosciences to Present at the Stifel 2024 Virtual Immunology and Inflammation Summit

MOUNTAIN VIEW, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today...

Form 8-K - Current report

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	6.4	56.7375886525	11.28	22.5	10.96	639739	16.60967628	CS
4	7.73	77.6884422111	9.95	22.5	9.18	285574	14.06166126	CS
12	10.9	160.766961652	6.78	22.5	6.1721	308959	10.99419934	CS
26	7.19	68.5414680648	10.49	22.5	6.1721	310132	9.93221406	CS
52	10.34	140.871934605	7.34	22.5	3.81	315546	9.19620117	CS
156	-55.37	-75.7973990418	73.05	76.2	3.81	351351	18.77770944	CS
260	-0.63	-3.44074276352	18.31	133	3.81	276083	30.45349628	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AAGRAfrican Agriculture Holdings Inc	$ 0.1251 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 62.9034 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.84 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 9.75 (0.00%)	0
AACGATA Creativity Global	$ 0.5342 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.1251 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 62.9034 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.84 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 9.75 (0.00%)	0
AACGATA Creativity Global	$ 0.5342 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.1251 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 62.9034 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.84 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 9.75 (0.00%)	0
AACGATA Creativity Global	$ 0.5342 (0.00%)	0